Breast cancer is the most common in women. One in nine will suffer breast cancer over their lifetime. Progress in prevention and early detection, and the use of chemotherapy after surgery (adjuvant chemotherapy), ...
Dec 10, 2014
5 / 5 (2) | 0
Diagnostic tool Oncotype DX associated with reduction in chemotherapy rates post-surgery in younger patients
In what's believed to be one of the largest population-based studies of Oncotype DX ever conducted, researchers at The University of Texas MD Anderson Cancer Center have found that the commercial diagnostic tool, Oncotype ...
Dec 11, 2014
not rated yet | 0